SEC Comment Letter 0000000000-24-009422 to BioCardia, Inc. (BCDA)

BioCardia, Inc.
Date: Aug. 16, 2024 · CIK: 0000925741 · Accession: 0000000000-24-009422

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-281448

Date

August 16, 2024

Author

Peter Altman

Form

UPLOAD

Company

BioCardia, Inc.

Letter

August 16, 2024 Peter Altman President and Chief Executive Officer BioCardia, Inc. 320 Soquel Way Sunnyvale, California 94085 Re:BioCardia, Inc. Registration Statement on Form S-1 Filed August 9, 2024 File No. 333-281448 Dear Peter Altman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Austin March, Esq.

Show Raw Text

August 16, 2024
Peter Altman
President and Chief Executive Officer
BioCardia, Inc.
320 Soquel Way
Sunnyvale, California 94085
Re:BioCardia, Inc.
Registration Statement on Form S-1
Filed August 9, 2024
File No. 333-281448
Dear Peter Altman:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Austin March, Esq.

SecProbe.io